Last reviewed · How we verify
NCT03144908
Healthcare Decisions on Dietary and Environmental Allergen Exposure
trial testing Standard Operating Procedures in Dietary Allergy in 200 participants. Status unknown.
1 May 2020
Quick facts
| Lead sponsor | Data Collection Analysis Business Management |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 May 2017 |
| Primary completion | 1 May 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Standard Operating Procedures
Conditions studied
- Dietary Allergy — all drugs for Dietary Allergy →
- Environmental Allergy — all drugs for Environmental Allergy →
Sponsor
Data Collection Analysis Business Management
Who can join
Eligibility, any sex, with Dietary Allergy or Environmental Allergy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Design of this study is to collect data and review Principal Investigators standard operating procedures on allergy testing and changes made to their specific SOP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03144908
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Data Collection Analysis Business Management trials
Trials by the same sponsor.
- NCT03781024 — A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care · unknown
- NCT03768011 — Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without · unknown
- NCT03322254 — How Respiratory Pathogens Panel Results Affect Patients' Plan of Care · unknown
- NCT03322176 — Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and P · unknown
- NCT03319290 — Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategi · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03144908 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Data Collection Analysis Business Management
- Last refreshed: 23 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03144908.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing